Medicare Enrolled

Dr. Larry Puthenparambil, MD

Retina Specialist (Ophthalmology) Physician · Pearland, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
8540 BROADWAY ST STE 210, Pearland, TX 77584
8327271771
In practice since 2008 (17 years)
NPI: 1679718506 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Puthenparambil from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Puthenparambil? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Puthenparambil

Dr. Larry Puthenparambil is a retina specialist (ophthalmology) physician in Pearland, TX, with 17 years in practice. Based on federal Medicare data, Dr. Puthenparambil performed 12,468 Medicare services across 1,571 unique beneficiaries.

Between the years covered by Open Payments, Dr. Puthenparambil received a total of $21,323 from 29 pharmaceutical and/or device companies across 135 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Puthenparambil is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 35% volume in TX$ $21,323 industry payments

Medicare Practice Summary

Medicare Utilization ↗
12,468
Medicare services
Top 35% in TX for retina specialist (ophthalmology) physician
1,571
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~733 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Eye injection (Vabysmo/faricimab)8,100$29$43
Comprehensive eye exam, established patient1,217$89$385
Retinal imaging (OCT scan)1,109$29$139
Aflibercept eye injection (Eylea)784$693$2,491
Eye injection for retinal disease620$102$480
Injection, bevacizumab, 10 mg175$52$298
Injection, dexamethasone, intravitreal implant, 0.1 mg168$151$295
Retinal photography (fundus photo)155$26$207
New patient office visit (45-59 min)45$96$478
Removal of recurring cataract in lens capsule using a laser28$262$1,175
Eye exam, established patient, focused21$70$266
Photocoagulation treatment to prevent detachment of retina18$195$2,769
Optic nerve imaging (OCT scan)15$20$135
New patient office visit, complex (60-74 min)13$130$615
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$21,323
Total received (2018-2024)
Avg $3,046/year across 7 years
Top 17% in TX for retina specialist (ophthalmology) physician
29
Companies
135
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$10,226 (48.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,725 (36.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,371 (15.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$980
2023
$1,884
2022
$9,763
2021
$650
2020
$2,152
2019
$179
2018
$5,715

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alimera Sciences, Inc.
$10,472
Allergan Inc.
$5,849
Allergan, Inc.
$2,156
ABBVIE INC.
$826
EyePoint Pharmaceuticals US, Inc.
$288
Novartis Pharmaceuticals Corporation
$232
Regeneron Healthcare Solutions, Inc.
$217
Dutch Ophthalmic, USA
$183
Alcon Vision LLC
$139
Mallinckrodt Hospital Products Inc.
$137
Genentech, Inc.
$137
Bausch & Lomb Americas Inc.
$101
Carl Zeiss Meditec USA, Inc.
$66
Oyster Point Pharma, Inc.
$63
Glaukos Corporation
$60
Apellis Pharmaceuticals, Inc.
$54
Aerie Pharmaceuticals, Inc.
$49
Sun Pharmaceutical Industries Inc.
$41
BioTissue Holdings, Inc.
$36
Notal Vision, Inc.
$35
SUN PHARMACEUTICAL INDUSTRIES INC.
$27
Johnson & Johnson Surgical Vision, Inc.
$24
Harrow Eye, LLC
$23
Coherus Biosciences Inc.
$23
Dompe US, Inc.
$22
Bausch & Lomb, a division of Bausch Health US, LLC
$16
EYEVANCE PHARMACEUTICALS LLC
$16
Genentech USA, Inc.
$15
Lumenis, Inc
$14
Top 3 companies account for 86.7% of total payments
Associated products mentioned in payments ›
ACTHAR · CIRRUS HD-OCT · Cequa · Cimerli · DURYSTA · EVA Ophthalmic Surgical System · EYLEA · Flarex · IHEEZO · ILUVIEN · Iluvien · KXL System · Lumenis Pulse 120H · OXERVATE · OZURDEX · PROKERA · RESTASIS MULTIDOSE · SUSVIMO · Stellaris · TOTAL30 · TYRVAYA · VISULAS 532s · VUITY · Vabysmo · XELPROS · XIIDRA · XIPERE · YUTIQ · enVista MX60 IOL · iStent infinite Trabecular Micro-Bypass System Model iS3 · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (48%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in retina specialist (ophthalmology) physician and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $171 per 100 Medicare services performed
Looking for a retina specialist (ophthalmology) physician in Pearland?
Compare retina specialist (ophthalmology) physicians in the Pearland area by procedure volume, costs, and industry payment transparency.
Browse retina specialist (ophthalmology) physicians nearby

Geographic Context

Retina Specialist (Ophthalmology) Physicians within 10 mi
19
Per 100K population
5.0
County median income
$95,155
Nearest hospital
HCA HOUSTON HEALTHCARE PEARLAND
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Puthenparambil is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 17%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Puthenparambil experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Puthenparambil performed 8,100 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Puthenparambil receive payments from pharmaceutical companies?
Yes. Dr. Puthenparambil received a total of $21,323 from 29 companies across 135 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Puthenparambil's costs compare to other retina specialist (ophthalmology) physicians in Pearland?
Dr. Puthenparambil's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Puthenparambil) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →